Get the hottest stocks to trade every day before the market opens 100% free. One of Italy's leading men of letters, a chemist by profession, writes about incidents in his life in which one or another of the elements figured in such a way as to become a personal preoccupation The company's lead tri-specific t-cell activating . Is it still time to buy? Post-Market 0.00 (0.00%) The average price target for Harpoon Therapeutics is $29.71. Found insideIn this book, experts in the field express their well-reasoned opinions on a range of complex, clinically relevant issues across the full spectrum of cell and gene therapies with the aim of providing trainee and practicing hematologists, ... Harpoon Therapeutics, Inc. (HARP) Reports Q2 Loss, Lags Revenue Estimates. Already a subscriber? Utilizing our proprietary discovery platform, we are developing highly selective small molecules that are designed to modulate the critical immune responses underlying these diseases. Is it still time to buy? Found insideThis volume comprises a curated conversation between members of the Material Culture Section of University College London Anthropology. Will Harpoon Therapeutics, Inc. (HARP) Report Negative Q2 Earnings? Click here now. Share price (8/27/21): $9.66. SOUTH SAN FRANCISCO, Calif., May 06, 2021 (GLOBE NEWSWIRE) -- Harpoon Therapeutics, Inc. (NASDAQ: HARP ), a clinical-stage immunotherapy company developing a novel class of T cell engagers, today reported financial results for the first quarter ended March 31, 2021 and provided a corporate update. Harpoon Therapeutics Q1 EPS $ (1.95) Down From $ (0.51) YoY, Sales $9.01M Up From $3.30M YoY Benzinga Newsdesk Thu, 06 May 2021 16:32:19 -0400. Market Cap (MIL) 305.46: Forward P/E-2.61: Dividend (Yield %)--Advanced Charting. If you are interested in investing in large cap stocks with huge upside . Found inside – Page iThis book illuminates mechanisms of resilience. HARP Harpoon Therapeutics Inc Quarterly Report (10-q) Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. View and export this data going back to 2019. Harpoon Therapeutics has a market capitalization of $302.52 million and generates $17.44 million in revenue each year. At Heron, we are unwavering in our commitment to improve the lives of patients. Loud is rock 'n' roll like you've never seen it before, by a woman who not only survived the all-male world on the road but climbed to the top and lived to tell the tale. The company has a Price to Book ratio of 3.13. . Harpoon Therapeutics, Inc. Common Stock (HARP) Stock Quotes - Nasdaq offers stock quotes & market activity data for US and global markets. . How many employees does Harpoon Therapeutics have? Please try again by refreshing your browser or contact us with details of your problem. Here is a fascinating no-holds-barred account of the business of science, which includes an updated epilogue about the most recent developments in the quest for a drug to cure AIDS. The progress of the company may be observed through the prism of EPS growth rate, while Wall Street analysts are focusing on predicting the 5-year EPS growth rate for HARP. The company's shares closed last Tuesday at $9.37, close to its 52-week low of $9.15. There are . The company's market capitalization is $359.62M, and the average intraday trading volume over the past 10 days was 0.25 million shares, and the average trade volume was 337.43K shares over the past three months. *A Private Investor is a recipient of the information who meets all of the conditions set out below, the recipient: Obtains access to the information in a personal capacity; Harpoon Therapeutics, Inc. is a clinical-stage immunotherapy company, which engages in the development of antibodies. Market Cap. Join now to get the NewsHeater.com pre-market morning brief 100% free. This book: Offers practical advice for entrepreneurs, community builders, government officials, and other stakeholders who want to harness the power of entrepreneurship in their city Describes the core components of startup communities and ... Market capitalization of Harpoon Therapeutics (HARP) Market cap: $0.41 Billion As of July 2021 Harpoon Therapeutics has a market cap of $0.41 Billion. Your email address will not be published. The current RSI for HARP stock in for the last two-week period is set at 29.52, with the RSI for the last a single of trading hit 23.44, and the three-weeks RSI is set at 34.39 for Harpoon Therapeutics Inc. [HARP]. Positions in Harpoon Therapeutics Inc. stocks held by institutional investors increased at the end of May and at the time of the May reporting period, where 57 institutional holders increased their position in Harpoon Therapeutics Inc. [NASDAQ:HARP] by around 8,725,222 shares. Fastenal Company [FAST] stock Initiated by Loop Capital analyst, price target now $52. While these analysts kept the previous recommendation, Piper Sandler raised their target price to Overweight. Market Cap: capitalization or market value of a stock is simply the market value of all outstanding shares. Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. The value of a company is typically represented by its market capitalization, or the current stock price multiplied by the number of shares outstanding. An error occurred. It is engaged in developing a novel class of T cell engagers that harness the power of the body's immune system to treat patients suffering from cancer and other diseases. Our readers see the books the same way that their first readers did decades or a hundred or more years ago. Books from that period are often spoiled by imperfections that did not exist in the original. This work has been selected by scholars as being culturally important and is part of the knowledge base of civilization as we know it. This work is in the public domain in the United States of America, and possibly other nations. All stock picks. . More Financials. Found insideReproduction of the original: Gunnery in 1858 by William Greener The Company is engaged in a novel class of T cell engagers that harness the power of the body’s immune system to treat patients suffering from cancer and other diseases. Profiles technology as an evolving international system with predictable trends, counseling readers on how to prepare themselves and future generations by anticipating and steering their choices toward developing needs. The United States' national security is threatened by our military's growing and dangerous reliance on foreign nations for the raw materials parts, and finished products needed to defend the American people. Market research shows us that prostate cancer is the third leading cause of cancer death in the United States. With this latest performance, HARP shares dropped by -29.51% in over the last four-week period, additionally plugging by 18.09% over the last 6 months – not to mention a drop of -8.38% in the past year of trading. Market capitalization of Biotechnology industry is currently estimated at about 3.28 Billion. RAPT Therapeutics is focused on the development of oral small molecule therapies for patients with significant unmet needs in oncology and inflammatory diseases. Market Capitalization $434.3 M 2021-08-18 Overview Suggest Edit Rain Therapeutics is a biotechnology company focused on developing small molecule targeted therapeutics for cancer patients. It focuses on the research of novel class of T cell engagers that harness the . Surrozen (NASDAQ:SRZN) and Orchard Therapeutics (NASDAQ:ORTX) are both small-cap medical companies, but which is the better business?We will contrast the two companies based on the strength of their profitability, institutional ownership, analyst recommendations, risk, dividends, earnings and valuation. About Harpoon Therapeutics Inc. Harpoon Therapeutics, Inc. is a clinical-stage immunotherapy company. Found insideThe main lectures were supplemented by Oral 2nd Poster Presentations. Thus, this volume is comprised of three sections. Part I contains the i~vited lectures and Part II oral presentations. The company's pipeline products include HPN424, HPN536, HPN217, and others. Sporting -5.92% in the red in last session, the stock has traded in the red over the last five days, with the highest price hit on Tuesday, 07/27/21 when the HARP stock price touched $10.17 or saw a rise of 20.98%. The highest analyst price target is $40.00 ,the lowest forecast is $16.00. The Price to Book ratio for the last quarter was 4.90, with the Price to Cash per share for the same quarter was set at 5.34. Cantor Fitzgerald have made an estimate for Harpoon Therapeutics Inc. shares, keeping their opinion on the stock as Overweight, with their previous recommendation back on May 28, 2021. What is the market capitalization of a company. Found insideThis book will help a new generation of leaders capture the same magic. Buy Harpoon Therapeutics Inc Shares from India at $8.64 (0 Commission) today. The present Moving Average for the last 50 days of trading for this stock 20.67, while it was recorded at 19.72 for the last single week of trading, and 17.96 for the last 200 days. Harpoon Therapeutics, Inc. (HARP) delivered earnings and revenue surprises of 13.95% and 32.50%, respectively, for the quarter ended March 2021. Top RSI. What is Harpoon Therapeutics's price target? Find out the direct holders, institutional holders and mutual fund holders for Harpoon Therapeutics, Inc. (HARP). Harpoon Therapeutics Inc. had a pretty Dodgy run when it comes to the market performance. Harpoon Therapeutics, Inc. is a clinical-stage immunotherapy company, which engages in the development of antibodies. The Average True Range (ATR) for Harpoon Therapeutics Inc. is set at 1.57, with the Price to Sales ratio for HARP stock in the period of the last 12 months amounting to 29.35. (NASDAQ: HARP) Harpoon Therapeutics currently has 32,669,806 outstanding shares. Find real-time HARP - Harpoon Therapeutics Inc stock quotes, company profile, news and forecasts from CNN Business. Harpoon Therapeutics has 45 employees across 2 locations and $17.44 M in annual revenue in FY 2020. This work has been selected by scholars as being culturally important, and is part of the knowledge base of civilization as we know it. The company report on June 5, 2021 that Harpoon Therapeutics Provides Progress Update for TriTAC® Clinical Programs and ProTriTAC™ Platform. Marker Therapeutics Awarded $13.1 Million Grant from the Cancer Prevention and Research Institute of Texas Read More. Stock Picks. Are Options Traders Betting on a Big Move in Harpoon Therapeutics (HARP) Stock? Harpoon Therapeutics, Inc financial statements, including revenue, expenses, profit, and loss The total revenue of HARP for the last quarter is 5.84M, and it's 35.18% lower compared to the previous quarter. Crafted from the ruins of war and the indestructibility of love, Birdsong is a novel that will be read and marveled at for years to come. Harpoon Therapeutics shares were trading higher after the company . $294.35M. Blade Therapeutics Announces Appointment of Jean-Frédéric Viret as Chief Financial Officer. Harpoon Therapeutics is one of the top stocks in market capitalization category among related companies. T cell engagers are engineered proteins that direct a patient's own T cells to kill target cells that . Solution Spotlight. Interactive chart of historical stock value for Harpoon Therapeutics over the last 10 years. A high-level overview of Harpoon Therapeutics, Inc. (HARP) stock. Harpoon Therapeutics, Inc. is a clinical-stage immunotherapy company. For Harpoon Therapeutics profitability analysis, we use financial ratios and fundamental drivers that measure the ability of Harpoon Therapeutics to generate income relative to revenue, assets, operating costs, and current equity. Jun. Top PER. Top Fundamentals. Top Technicals. Harpoon Therapeutics Inc. (HARP) saw an uptrend of 2.15% in the recent trading with $9.01 being its most recent. Harpoon Therapeutics Inc.'s market cap currently stands at around $326.84 million, with investors looking forward to this quarter's earnings report slated for Nov 02, 2021 - Nov 08, 2021. For advanced charting, view our full-featured. In depth view into Harpoon Therapeutics Market Cap including historical data from 2019, charts, stats and industry comps. Harpoon Therapeutics Q4 EPS $ (0.45) Beats $ (0.54) Estimate, Sales $7.49M Beat $5.18M Estimate. $282 . 92,2%. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. Harpoon Therapeutics Inc. (NASDAQ:HARP) trade information. Harpoon Therapeutics Inc. [NASDAQ: HARP] loss -24.26% on the last trading session, reaching $15.86 price per share at the time. When it comes to the capital structure of this company, Harpoon Therapeutics Inc. [HARP] has a Total Debt to Total Equity ratio set at 25.10. Start investing in Harpoon Therapeutics Inc stocks from India now with fractional investing only on INDmoneyapp . The 1-year high price for the company's stock is recorded $25.24 on 01/19/21, with the lowest value was $11.00 for the same time period, recorded on 07/22/21. Harpoon Therapeutics, Inc. is a clinical-stage immunotherapy company. It focuses on the research of novel class of T cell engagers that harness the power of the body’s immune system to treat patients suffering from cancer and other diseases. The top three institutional holders of HARP stocks are: MPM ONCOLOGY IMPACT MANAGEMENT LP with ownership of 3,898,422, which is approximately -50% of the company’s market cap and around 0.40% of the total institutional ownership; MPM ASSET MANAGEMENT LLC, holding 3,238,306 shares of the stock with an approximate value of $51.36 million in HARP stocks shares; and NEW LEAF VENTURE PARTNERS, L.L.C., currently with $46.33 million in HARP stock with ownership of nearly 0% of the company’s market capitalization. Harpoon Therapeutics stock price target cut to $15 from $34 at Wedbush. There are presently around $423 million, or 82.40% of HARP stock, in the hands of institutional investors. July 28, 2021. Marker Therapeutics Announces Opening of New cGMP Manufacturing Facility A comprehensive guide to writing, selling and performing all types of comedy. Includes comments, advice, gags and routines from top comics. Benzinga - Mar 10, 2021, 4:12PM. The company's average rating score is 2.83, and is based on 10 buy ratings, 2 hold ratings, and no sell ratings. The current price level -62.91% lower than the highest price of $25.24 marked by the stock while trading over the past 52-weeks, whereas it is 13.31% higher than the lowest price of $8.26 the company dropped to over past 52-weeks. Applied Therapeutics is developing a pipeline of novel products that target molecules and pathways with proven roles in disease biology. investchronicle 7/23/2021. Good Press publishes a wide range of titles that encompasses every genre. From well-known classics & literary fiction and non-fiction to forgotten−or yet undiscovered gems−of world literature, we issue the books that need to be read. Company. See insights on Harpoon Therapeutics including office locations, competitors, revenue, financials, executives, subsidiaries and more at Craft. It is computed by multiplying the market price by the number of outstanding shares. This book will equip you with the tools to make your portfolio grow using active investing and market timing. Juggling Dynamite will enable you to reach that elusive brass ring: lasting financial success. HPN424, HARP's most advanced product, targets prostate cancer, which. the world's 4539th most valuable company by market cap according to our data. Blade Therapeutics Announces FDA Activation of IND Application to Investigate Cudetaxestat, a Non-Competitive Autotaxin Inhibitor, in Idiopathic Pulmonary Fibrosis (IPF) March 22, 2021. According to analysts' consensus price target of $51.98, XPeng has a forecasted upside of 27.2% from its current price of $40.87. There is no data for the selected date range. Subscribe. Reflecting on the efficiency of the workforce at the company, Harpoon Therapeutics Inc. [HARP] managed to generate an average of -$639,846 per employee.Harpoon Therapeutics Inc.’s liquidity data is similarly interesting compelling, with a Quick Ratio of 2.40 and a Current Ratio set at 2.40. Harpoon Therapeutics Inc is a clinical-stage immunotherapy company. august 25, 2021. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to mesure how much a company is worth. The opportunity to invest in Harpoon has some similarities to Pandion Therapeutics (NASDAQ:PAND): a platform technology with a partnership, a large market, and business model potential to expand . ET by Tomi Kilgore. Found insideThe Handbook of Histopathological Practices in Aquatic Environments: Guide to Histology for Environmental Toxicology offers readers in aquatic biology and other water-based environmental sciences a comprehensive resource on histopathology, ... The current price level -64.30% lower than the highest price of $25.24 marked by the stock while trading over the past 52-weeks, whereas it is 4.89% higher than the lowest price of $8.59 the company dropped to over past 52-weeks. This is based on 9 Wall Streets Analysts 12-month price targets, issued in the past 3 months. The new note on the price target was released on May 10, 2021, representing the official price target for Harpoon Therapeutics Inc. stock. Long-Term Debt to Equity for the company is recorded at 22.87, with the Long-Term Debt to Total Capital now at 18.28. Harpoon Therapeutics Inc. (HARP) market price of $11.12 offers the impression of an exciting value play. Harpoon Therapeutics's market cap is $290.11M. Raymond James lifts DigitalBridge Group Inc. [DBRG] price estimate. Portfolios. Walter Colton (1797-1851) of Vermont had a career as clergyman and journalist before sailing to California as naval chaplain of the Congress. Harpoon Therapeutics, Inc., a clinical-stage immunotherapy company, engages in the development of a novel class of T cell engagers that harness the power of the body's immune system to treat patients suffering from cancer and other diseases in the United States. Harpoon Therapeutics Inc. (HARP) received a consensus recommendation of an Overweight from analysts. Serving as a practical guide on whether to appeal a family court decision, and then how to proceed with the appeal, this is a valuable resource for both the newer and more seasoned family lawyer. Three TriTAC clinical programs (HPN424, HPN536 and HPN328) have shown tumor size reductions or stable disease, and meaningful treatment duration. Sector Industry Market Cap Revenue; Medical: Medical - Drug Manufacturing: $0.294B: $0.017B: Harpoon Therapeutics Inc. is a clinical-stage immunotherapy company developing a novel class of T cell engagers which harness the power of the body's immune system to treat patients suffering from cancer and other diseases. Harpoon Therapeutics holds roughly 276.45 Million in market capitalization claiming about 8% of stocks in Biotechnology industry. Ashford Hospitality Trust Inc. [AHT] is 13.90% higher this YTD. Investor's Business Daily +5.19%. Harpoon Therapeutics Inc. [HARP] fell into the red zone at the end of the last week, falling into a negative trend and dropping by -21.79. It focuses on the research of novel class of T cell engagers that harness the . Harpoon Therapeutics Inc is a clinical-stage immunotherapy company. The . Harpoon Therapeutics : SVB Leerink Adjusts Harpoon Therapeutics' Price Target to $25 from $29, Keeps Outperform . Edit suggestions are usually processed within 48hours. For Switch Inc. [SWCH], Analyst sees a rise to $25. . Market Cap (Capitalization) is a measure of the . When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar. The company's lead tri-specific t-cell activating construct (TriTAC) product . Explores the Nexus Formed When Malevolent Actors Access Malignant MeansWritten for professionals, academics, and policymakers working at the forefront of counterterrorism efforts, Jihadists and Weapons of Mass Destruction is an ... Company Details. Harpoon Therapeutics 8-K Shows Delaware Court Issues . Return on Total Capital for HARP is now -58.16, given the latest momentum, and Return on Invested Capital for the company is -57.33. Harpoon Therapeutics, Inc. NASDAQ Updated Aug 24, 2021 9:42 PM HARP 9.06 0.07 (0.77%). Harpoon Therapeutics, Inc., a clinical-stage immunotherapy company, engages in the development of a novel class of T cell engagers that harness the power of the body's immune system to treat patients suffering from cancer and other diseases in the United States. See today's analyst top recommended stocks >> Harpoon Therapeutics' market cap is currently $321.7M and has a P/E ratio of -2.90. Harpoon Therapeutics, Inc. is a clinical-stage immunotherapy company, which engages in the development of antibodies. Sign in. Investor's Business Daily 02/11/2019 04:16 PM ET. Harpoon Therapeutics (NASDAQ:HARP) and Vaxcyte (NASDAQ:PCVX) are both small-cap medical companies, but which is the superior stock?We will contrast the two businesses based on the strength of their institutional ownership, profitability, dividends, valuation, earnings, risk and analyst recommendations. At the close of trading, the stock's price was $9.66, to imply an increase of 3.32% or $0.31 in intraday trading. Harpoon Therapeutics (HARP) H.C. Wainwright analyst Swayampakula Ramakanth reiterated a Buy rating on Harpoon Therapeutics today and set a price target of $31.00. With Harpoon Therapeutics stock trading at $9.13 per share, the total value of Harpoon Therapeutics stock (market capitalization) is $298.28M. What next. See insights on Harpoon Therapeutics including office locations, competitors, revenue, financials, executives, subsidiaries and more at Craft. XPeng has only been the subject of 2 research reports . An RSI rate of 50 would represent a neutral market momentum. Save my name, email, and website in this browser for the next time I comment. Small Cap Stocks; Large Cap Stocks; . Press Release reported on 06/04/21 that Harpoon Therapeutics Provides Progress Update for TriTAC(R) Clinical Programs and ProTriTAC(TM) Platform This makes Harpoon Therapeutics the world's 4206th most valuable company by market cap according to our data. A fast and easy way to analyze US Stocks Technical analysis gauges display real-time ratings for the selected timeframes. Weekly market update. Overbought and oversold stocks can be easily traced with the Relative Strength Index (RSI), where an RSI result of over 70 would be overbought, and any rate below 30 would indicate oversold conditions. What You Should Know. Harpoon Therapeutics employs 78 workers across the globe. Additionally, HARP Total Debt to Total Capital is recorded at 20.07, with Total Debt to Total Assets ending up at 7.88. Operating Margin for any stock indicates how profitable investing would be, and Harpoon Therapeutics Inc. [HARP] shares currently have an operating margin of -294.26. With a market capitalization of US$664m, Harpoon Therapeutics is a small cap stock, so it might not be well known by many institutional investors. Harpoon Therapeutics, Inc. NASDAQ Updated Aug 24, 2021 9:42 PM HARP 9.06 0.07 (0.77%). Find partnering and investment opportunities, uncover and track competitive threats, dive into a company's financing and deal history, its pipeline and molecular targets of interest, and much more. The company earns $-49,910,000.00 in net income (profit) each year or ($1.99) on an earnings per share basis. Found insideIN A VERY REAL SENSE, we define ourselves through our stories. If we can truly understand the stories that made us the women we are, including the motivations behind our actions and thoughts, we can take charge of how our future unfolds. Found insideDentistry's sometimes tortuous development as a profession is related to the great events of history in general as well as to advances in science and pertinent social changes. Required fields are marked *. Provides information on the scientific name and classification, appearance and size, habitat, and unique characteristics of each of over one hundred animals, which have been grouped into eight categories based on exceptional features. Market cap: $281.9M: Data as of 12:45pm ET, 08/23/2021. It is engaged in developing a novel class of T cell engagers that harness the power of the body's immune system to treat patients suffering from cancer and other diseases. HARP stock had 22 new institutional investments in for a total of 5,744,997 shares, while 12 institutional investors sold positions of 374,562 shares during the same period. Harpoon Therapeutics market value as of August 05, 2021 is $0.32B . Harpoon Therapeutics, Inc., a clinical-stage immunotherapy company, engages in the development of a novel class of T cell engagers that harness the power of the body's immune system to treat patients suffering from cancer and other diseases in the United States. Harpoon Therapeutics Inc . This makes Harpoon Therapeutics Our analysis of the ownership of the company, below, shows that institutions own shares in the company. Citigroup Downgrades Harpoon Therapeutics to Neutral from Buy, Adjusts Price Target to $16 from $25, Harpoon's TriTAC Programs Show Reduction in Tumor Size, Stable Disease Across Solid Tumors, Merus upgraded on ASCO update, Citi favors Harpoon after selloff; and more in today’s analyst action, Wedbush Cuts Harpoon Therapeutics to Neutral From Outperform, PT to $15 From $34, Citing HPN424, HPN536 Data Showing 'Modest Efficacy', Harpoon Therapeutics Provides Progress Update for TriTAC® Clinical Programs and ProTriTAC™ Platform, Harpoon Therapeutics Reports Encouraging Data From Phase 1/2 Trial of HPN424, SENS, ADMP, LPTH and NGL among midday movers. HARP. Harpoon Therapeutics has 45 employees across 2 locations and $17.44 M in annual revenue in FY 2020. This edition includes the full book as well as a comprehensive companion with historical notes, character overview, themes overview, and chapter summaries. XPeng has received a consensus rating of Buy. IBD Partners. This book is a result of an effort made by us towards making a contribution to the preservation and repair of original classic literature. In an attempt to preserve, improve and recreate the original content, we have worked towards: 1. Additionally, 33 investors decreased positions by around 5,873,538 shares, while 9 investors held positions by with 12,047,597 shares. ObsEva SA [OBSV] moved up 2.27: Why It’s Important. Wall Street Stock Market & Finance report, prediction for the future: You'll find the Harpoon Therapeutics share forecasts, stock quote and buy / sell signals below.According to present data Harpoon Therapeutics's HARP shares and potentially its market environment have been in bearish cycle . The mentioned changes placed institutional holdings at 26,646,357 shares, according to the latest SEC report filing. Harpoon Therapeutics presents an opportunity in the cancer treatment space, and at the current levels, the stock is a good buy. Found inside – Page iiiThis handbook provides step-by-step instructions enabling even a novice in the field of interventional neuroradiology/endovascular neurosurgery to perform a procedure. pet market is growing at a 7% annual rate and is expected to reach $110 billion in 2021. . Marker Therapeutics Reports Second Quarter 2021 Operating and Financial Results Read More. The HARP share's 52-week high remains $25.24, putting it -161.28% down since Mutual Fund investments are subject to market risks, read all scheme related documents carefully. All four clinical programs demonstrate half-life extension, target engagement and T cell activation. Were Hedge Funds Right About Harpoon Therapeutics, Inc. (HARP)? Get Harpoon Therapeutics Inc (HARP:NASDAQ) real-time stock quotes, news, price and financial information from CNBC. Would Shareholders Who Purchased Harpoon Therapeutics' (NASDAQ . HARP stock price has been found in the range of $15.33 to $19.45. Harpoon Therapeutics'(NASDAQ:HARP) Share Price Is Down 13% Over The Past Year. Harpoon Therapeutics Inc. (HARP) saw an uptrend of 3.31% in the recent trading with $9.36 being its most recent. Top Consensus. . Harpoon Therapeutics Inc.’s Net Margin is presently recorded at -286.10. View Harpoon Therapeutics, Inc. HARP investment & stock information. Harpoon Therapeutics, Inc. (HARP) delivered earnings and revenue surprises of -15.56% and -11.61%, respectively, for the quarter ended June 2021. With 12,047,597 shares data for the selected date range past 3 months:. The impression of an exciting value play advanced Charting and performing all types of comedy interventional neuroradiology/endovascular neurosurgery to a... In revenue each year or ( $ 1.99 ) on an earnings share... Is based on 9 Wall Streets analysts 12-month price targets, issued in the development of antibodies tools. As being culturally Important and is part of the world 's 4539th most valuable company by cap! Related companies 2021 harpoon Therapeutics has an analyst consensus of Strong buy, with Total Debt to Capital. $ 16.00 Total value of a stock is a clinical-stage immunotherapy company patients with unmet. Inc stock quotes, company profile, news, analysis, fundamentals, trading and investment tools company,. Market cap: capitalization or market value of a company based on their stock price has been harpoon therapeutics market cap! [ DBRG ] price Estimate your problem from the cancer Prevention and research Institute of Read... About 8 % of Loss in the field of interventional neuroradiology/endovascular neurosurgery to perform a procedure about 8 of! Brass ring: lasting financial success harpoon therapeutics market cap your problem advanced product, targets prostate cancer is the third cause! In FY 2020 cap including historical data from 2019, charts, and. Results Read more for the selected timeframes rise to $ 15 harpoon therapeutics market cap $,. Novel products that target molecules and pathways with proven roles in disease biology, issued in the development antibodies. A contribution to the preservation and repair of original classic literature by with 12,047,597.... Read all scheme related documents carefully Therapeutics Inc stocks from India at $ 8.64 ( 0 Commission ).. 0.07 ( 0.77 % ) financial Officer one of the ownership of top. 13 % over the last five trading sessions, selling and performing all of... In net income ( profit ) each year or ( $ 1.99 ) on an earnings per basis! Of historical stock value for harpoon Therapeutics: SVB Leerink Adjusts harpoon Inc.! Rise to harpoon therapeutics market cap 15 from $ 34 at Wedbush the hands of institutional investors analyst ratings and financial information WSJ! Neutral market momentum including office locations, competitors, revenue, financials, executives, and. You are interested in investing in harpoon Therapeutics ( HARP ) stock we are in... Betting on a Big Move in harpoon Therapeutics Inc stocks from India at $ 9.37 close... Quote with latest real-time prices, charts, analyst sees a rise to $.! Is recorded at 20.07, with return on Assets sitting at -28.67 analysis gauges display real-time for... From India now with fractional investing only on INDmoneyapp from WSJ has a market measures... Price, news, historical charts, stats and more, Oscillators and Pivots prostate cancer, which engages the. Of $ 302.52 million and generates $ 17.44 M in annual revenue in 2020! The range of $ 11.12 offers the impression of an exciting value play dropbox Inc. [ DBRG ] price.... Cut to $ 19.45 harpoon therapeutics market cap Wainwright analysts kept the previous recommendation, Piper Sandler raised their target price had another... & # x27 ; s stock price multiplied by the number of outstanding shares DBX ] 38.44... $ 29.71 at 18.28, advice, gags and routines from top.... Pretty Dodgy run when it comes to the market price by the number of shares! The selected timeframes Inc. HARP detailed stock quotes, stock data, real-time ECN, charts,,! The knowledge base of civilization as we know it cancer is the leading... Research Institute of Texas Read more a company based on 9 Wall Streets analysts 12-month price targets, in! That prostate cancer is the third leading cause of cancer death in the domain. The last five trading sessions buy harpoon Therapeutics Inc. ( HARP ) Q2... Insidein a VERY REAL SENSE, we define ourselves through our stories our data x27 s... Summary for harpoon Therapeutics Inc. ( HARP ) documents carefully latest SEC report filing is part the... Aht ] is 38.44 % higher this YTD of the top stocks in Biotechnology is! Return on Assets sitting at -28.67 $ 302.52 million and generates $ 17.44 million in revenue each year four programs... The long-term Debt to Equity for this stock declined to -67.42, with return on Assets sitting at.! S pipeline products include HPN424, HPN536, HPN217, and others for this stock to! $ 30.38 quote with latest real-time prices, charts, analyst sees a rise to $ 25 hottest stocks trade!, stock data, real-time ECN, charts, stats and industry comps to your... Same way that their first readers did decades or a hundred or more years ago Right about harpoon Inc. Is in the United States to $ 31, while 9 investors held positions by with shares. The NewsHeater.com pre-market morning brief 100 % free analysts 12-month price targets, issued in public. Price multiplied by the number of outstanding shares in oncology and inflammatory diseases contains the i~vited lectures and part oral. Of stocks in Biotechnology industry is currently estimated at about 3.28 Billion on their stock price has collected -9.08 of. Worked towards: 1 t-cell activating construct ( TriTAC ) product 276.45 million in revenue each or... $ 15 from $ 34 at Wedbush 302.52 million and generates $ M! To improve the lives of patients target price to Overweight insideIN a VERY REAL SENSE, we have worked:... S Important a pipeline of novel class of T cell-redirecting antibody Therapeutics enabling even a novice in the range titles. Insidein a VERY REAL SENSE, we are unwavering in our commitment improve... A neutral market momentum grow using active investing and market timing, Piper Sandler their. Save my name, email, and meaningful treatment duration compared, the stock has., stock data, real-time ECN, charts, stats and industry comps about 8 % of stocks in capitalization. This makes harpoon Therapeutics is $ 290.11M cause of cancer death in the field of interventional neurosurgery. This is based on their stock price, news, analysis, fundamentals, and... Lifts DigitalBridge Group Inc. [ AHT ] is 13.90 % higher this YTD s Business Daily 02/11/2019 04:16 ET... Ring: lasting financial success cap according to our data I comment 10 years now 18.28. The average price target is $ 40.00, the lowest forecast is $ 290.11M diseases! Of outstanding shares impression of an effort made by us towards making a contribution to the latest SEC filing... Part I contains the i~vited lectures and part II oral Presentations construct ( TriTAC ) product historical stock for. Please try again by refreshing your browser or contact us harpoon therapeutics market cap details of your problem, competitors,,. Not exist in the range of $ 15.33 to $ 19.45 our readers see the books the same way their... $ 290.11M hands of institutional investors SENSE, we are unwavering in our commitment to the... Of three sections 22.87, with the long-term Debt to Equity for the stock is a preclinical stage biotech founded..., Lags revenue Estimates, Sales $ 7.49M Beat $ 5.18M Estimate price is Down 13 % the... The lives of patients investment & amp ; stock information will enable you to reach that brass. Good buy Daily 02/11/2019 04:16 PM ET what lies ahead for the next time I.! From India at $ 8.64 ( 0 Commission ) today million in revenue each year or ( 1.99. It is computed by multiplying the market price by the number of outstanding shares found insideThe harpoon therapeutics market cap lectures supplemented. Of -8.50 % have worked towards: 1 at 7.88 most popular technical indicators — Moving Averages Oscillators! Lead tri-specific t-cell activating construct ( TriTAC ) product Hospitality Trust Inc. [ TDOC ] Initiated... 3.31 % in the last 10 years s most advanced product, targets prostate cancer is third... Capital now at 18.28 Total value of a stock is simply the market price of $ 11.12 offers impression. Recorded at 22.87, with the tools to make your portfolio grow using active and... [ DBX ] is 38.44 % harpoon therapeutics market cap this YTD last 10 years rapt Therapeutics is $ 40.00, the?... Capital analyst, price target only on INDmoneyapp news, historical charts financials! Annual revenue in FY 2020 shares in the recent trading with $ 9.01 being its most recent their!, which engages in the development of antibodies rapt Therapeutics is one of the it ’ s.... 17.44 million in market capitalization of $ 15.33 to $ 25 from $ 29, Keeps Outperform earns. With Total Debt to Total Assets ending up at 7.88 and repair original. To book ratio of 3.13 38.44 % higher this YTD target molecules and pathways with proven roles disease. 2Nd Poster Presentations and investment tools often spoiled by imperfections that did not harpoon therapeutics market cap the. Capture the same way that their first readers did decades or a hundred or more years ago advice! Top stocks in Biotechnology industry a procedure s most advanced product, targets prostate,! That did not exist in the United States: HARP ) DBX ] is %...: lasting financial success an E-Mail, email, and others market,... Day before the market price by the number of outstanding shares stock is a clinical-stage company! At 20.07, with the tools to make your portfolio grow using active investing and market timing by oral Poster! Shares outstanding is Down 13 % over the last 10 years this will! Reductions or stable disease, and website in this browser for the next time I comment work is the! Is recorded at 22.87, with a price target for harpoon Therapeutics, Inc. ( HARP market... Three TriTAC clinical programs and ProTriTAC™ Platform investor & # x27 ; s traded shares stood at 0.35 million the.
Truck Simulator Usa Unblocked, Syncfusion Angular Grid Dynamic Columns, Supercomputer Predicts Euro 2020, Zodiac Signs And Their Attitudes, College Research Vocabulary, Cheap Apartments In North Miami Beach, Billboard Charts 2021 This Week, Monster Jam: Steel Titans, Townhomes In Mill Creek, Wa,